Proto Labs (NYSE:PRLB) Stock: Insider Daniel Schumacher Sells 5,000 Shares

Proto Labs, Inc. (NYSE:PRLB) CFO Daniel Schumacher sold 5,000 shares of Proto Labs stock in a transaction that occurred on Thursday, September 24th. The stock was sold at an average price of $95.32, for a total value of $476,600.00. Following the sale, the chief financial officer directly owned 35,019 shares of the company’s stock, valued at approximately $3,338,011.08. The trade was a 12.49% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Daniel Schumacher also recently made the following trade(s):

• On Thursday, September 17th, Daniel Schumacher sold 4,900 shares of Proto Labs stock. The stock was sold at an average price of $85.21, for a total transaction of $417,529.00.
• On Wednesday, September 16th, Daniel Schumacher sold 100 shares of Proto Labs stock. The shares were sold at an average price of $85.00, for a total value of $8,500.00.

Proto Labs Price Performance

PRLB stock traded up $3.21 during midday trading on Friday, reaching $96.19. The company had a trading volume of 255,948 shares, compared to its average volume of 198,289. The company has a market capitalization of $2.30 billion, a price-to-earnings ratio of 76.95 and a beta of 1.42. The stock has a 50 day moving average price of $82.48 and a 200-day moving average price of $73.55. Proto Labs, Inc. has a 1-year low of $45.10 and a 1-year high of $96.92.

Proto Labs (NYSE:PRLB) last posted its quarterly earnings results on Friday, July 31st. The industrial products company reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.53 by $0.07. Proto Labs had a net margin of 5.44% and a return on equity of 4.80%. The business had revenue of $149.34 million for the quarter, compared to analyst estimates of $144.53 million. During the same quarter last year, the business posted $0.41 EPS. The firm’s revenue for the quarter was up 10.5% on a year-over-year basis. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. As a group, research analysts anticipate that Proto Labs, Inc. will post 1.46 earnings per share for the current year.

Institutional Trading of Proto Labs

A number of institutional investors and hedge funds have recently bought and sold shares of PRLB. BlackRock Inc. bought a new stake in Proto Labs in the second quarter worth about $317,581,000. American Capital Management Inc. bought a new stake in shares of Proto Labs in the 2nd quarter worth approximately $50,524,000. S Squared Technology LLC purchased a new position in Proto Labs in the second quarter valued at approximately $23,484,661. Auto Owners Insurance Co lifted its stake in Proto Labs by 4,959.0% in the fourth quarter. Auto Owners Insurance Co now owns 227,655 shares of the industrial products company’s stock valued at $11,517,000 after purchasing an additional 223,155 shares during the last quarter. Finally, Bank of New York Mellon Corp bought a new position in Proto Labs during the second quarter valued at $11,720,000. 84.54% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages recently commented on PRLB. Zacks Research raised shares of Proto Labs from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 6th. Weiss Ratings downgraded shares of Proto Labs from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, September 18th. Benchmark increased their price target on Proto Labs from $70.00 to $91.00 and gave the company a “buy” rating in a research note on Thursday, July 2nd. Needham & Company LLC raised Proto Labs from a “hold” rating to a “buy” rating and set a $87.00 price objective on the stock in a report on Monday, August 3rd. Finally, Wall Street Zen lowered Proto Labs from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 18th. One investment analyst has rated the stock with a Strong Buy rating and three have issued a Buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $89.00.

About Proto Labs

Proto Labs, Inc (NYSE: PRLB), doing business as Protolabs, is a digital manufacturing company that provides rapid prototyping and on-demand production services. Its platform enables engineers and product developers to upload three-dimensional computer-aided design files, receive automated design analyses and quotes, and order custom parts through a streamlined online process.

The company offers computer numerical control machining, injection molding, 3D printing and sheet-metal fabrication.